From what I've read & interpreted Cannophen is simply a branded means of oral delivery they are licensing. Cannaphen isn't actually one specific thing, or at least they certainly have not presented it as such. Everything they have stated conveys it is some sort of "metered dosing" system capsule. It would be up to whoever decides to license the name "Cannophen" for their oral product to decide what marijuana strain or ingredient will fill the capsule, and the desired result or effect will depend on those ingredients. This is NOT a pure "pharmaceutical" play as such, it is a licensing play....for instance "Cannophen for nausea treatment" or "Cannophen for anxiety cessation" etc. would each be different but licensed as "Cannophen brand." Common sense would dictate as such, because a strain you would use to help induce sleepiness would certainly not be the same as a strain that produce an alert/energetic effect.
If there IS a plan for Cannophen to be a SINGULAR strain or treatment for one specific ailment, the company has done NOTHING to present it as such. My gut tells me this pink sheet stock/shell company eventually will produce a hemp derived (not marijuana) CBD capsule called "Cannophen" so they can sell it online, claiming to help with everything that ails. There are HUNDREDS of such products on the market presently. Nothing special by any means.
If I have misinterpreted, blame the lack of specifics from the company. You are of course encouraged to dig through the press releases and come to your own conclusions.
News 
Market Data 
Discover 
